Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03461536 · ClinicalTrials.gov registry record · NA

Ultrasound First Clinical Decision Support for Suspected Nephrolithiasis

A NA study of Nephrolithiasis, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
388
Enrollment target
1
Study location

NCT03461536 is a NA study of Nephrolithiasis that has completed, run by University of California, San Francisco. The registered enrollment target is 388 participants, above the 100-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (288% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03461536, a NA study of Nephrolithiasis, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
388 participants
Enrollment target
1
Study location

Study Summary

This is a randomized trial to determine the effectiveness of a clinical decision support tool on image ordering for patients with suspected nephrolithiasis. Patients who present with acute unilateral flank or abdominal pain in whom emergency department providers suspect nephrolithiasis will receive either the clinical decision support tool or no tool (usual care).

Conditions Studied

Interventions

  • BEHAVIORAL Ultrasound-first Clinical Decision Support tool

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 388 participants
Start Date 2019-01-02
Est. Completion 2019-12-19
Phase NA

What the Registry Record Tells You About NCT03461536

The ClinicalTrials.gov registry entry for NCT03461536 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 388 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 100-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (288% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nephrolithiasis appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound-first Clinical Decision Support tool is the first listed.

NCT03461536 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03461536 about?

NCT03461536 is a clinical study titled "Ultrasound First Clinical Decision Support for Suspected Nephrolithiasis". This is a randomized trial to determine the effectiveness of a clinical decision support tool on image ordering for patients with suspected nephrolithiasis. Patients who present with acute unilateral flank or abdominal pain in whom emergency department providers suspect nephrolithiasis will receive ...

What is the current status of trial NCT03461536?

This trial is currently completed. It is a NA study. The enrollment target is 388 participants. The study started on 2019-01-02. Estimated completion is 2019-12-19.

What conditions does trial NCT03461536 study?

This clinical trial studies the following conditions: Nephrolithiasis.

What interventions are being tested in trial NCT03461536?

The interventions under investigation include: Ultrasound-first Clinical Decision Support tool (BEHAVIORAL).

Who is sponsoring clinical trial NCT03461536?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03461536 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nephrolithiasis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.